Dossier
biotech drug trials
Coverage of biotech drug trials in the Nexus archive.
- Kalshi bets on Wall Street
Kalshi expanded its presence on Wall Street by launching 13 new contracts for betting on biotech drug trial outcomes and expanding contracts tracking AI compute costs. The platform also introduced a Bloomberg terminal-like tool and emphasized institutional financial market integration, including efforts to combat insider trading.